Antibodies and herd immunity (PIENTER Corona Study)
RIVMNational Institute for Public Health and the Environment has launched a large-scale study on immunity to COVID-19. This multi-year study investigates how many people have antibodies for the coronavirus SARS-CoV-2. Read more about the PIENTER Corona Study.
Research on behaviour and health provides insights into how to help people to continue following behavioural rules. Read more about behavioural science.
Families and young people (First Few Hundred Study)
RIVM is carrying out research among families in the Netherlands where someone has contracted the coronavirus SARS-CoV-2. We want to find out more about the course of the disease. Read more about research on families and young people.
RIVM keeps abreast of the spread of infectious diseases in various different ways. This also applies to the coronavirus SARS-CoV-2. One of the ways is by observing people with symptoms that could indicate an infection. This is done via an Infection Radar. Read more about Infectieradar (Dutch only).
Modelling the spread of the virus
Using data from research in the Netherlands, RIVM can estimate the course of the outbreak and calculate the effect of measures. Read more about modelling.
Since the 2009 flu epidemic, RIVM has been monitoring weekly deaths in consultation with Statistics Netherlands (CBS). The aim of monitoring mortality figures is to assess the impact of unusual circumstances on the number of people who died – for example due to a heat wave, a wave of seasonal influenza, or the current COVID-19 epidemic. Read more about Mortality monitor.
Netherlands Institute for Health Services Research (Nivel) monitoring stations
Nivel is working with RIVM on screening for people with flu-like symptoms. Working together, they are running tests at 40 General Practitioner (GP) practices to see how often these symptoms occur and which viruses are causing these symptoms. Read more about Nivel monitoring stations.
Q fever and COVID-19
is researching whether people who previously had Q fever have an increased risk of contracting COVID-19. Read more about Q fever and COVID-19.
RIVM is conducting laboratory research to see how the coronavirus SARS-CoV-2 is changing and what this means for the spread of the virus in the Netherlands. Read more about pathogen surveillance.
Genetic material from the coronavirus SARS-CoV-2 has been detected in sewage in the Netherlands. Read more about COVID-19 sewage research.
Transmission of coronavirus SARS-CoV-2 at primary schools
Initiated by RIVM, various studies are being conducted on the role that children play in the spread of the coronavirus SARS-CoV-2.
Vaccination Study on the Coronavirus (VASCO)
The Vaccination Study on the Coronavirus (VASCO) is researching the effectiveness of the COVID-19 vaccinations in the population of the Netherlands.
More COVID-19 research in the Netherlands
More research is being conducted into COVID-19 in the Netherlands. An overview can be found on the FMS website. Also, new research programmes on COVID-19 have been set up with the help of government grants. More information.
COVID-19 research in EU projects
UMC Utrecht, Utrecht University, RIVM , the Netherlands Pharmacovigilance Centre Lareb and research institute PHARMO are involved in the European project ACCESS (Vaccine COVID-19 monitoring ReadinESS). Read more.
RIVM and Radboud University Medical Centre are collaborating on the PANDEM-2 project. This project aims to increase and strengthen preparedness for and response to future pandemics. In that context, sharing information and collaborating are very important in order to protect the health and safety of people across the European Union. The PANDEM-2 project is funded by the European Union through Horizon 2020. The team from the Netherlands includes experts from Radboudumc and RIVM. Read the Radboudumc press release (in Dutch).